Is IOL Chemicals and Pharmaceuticals the Best Stock in Its Sector? A Look at the Numbers
- September 29, 2026
- Posted by: Harsh Piplani
- Category: Market
IOL Chemicals and Pharmaceuticals CMP Rs 198 (29 Sep 2026). Market cap Rs 5,765 Cr. ROE 7.65%. P/E 34.28x versus Industry P/E 38.42x.
Quick Answer
IOL Chemicals and Pharmaceuticals is one of the names investors compare when screening the Healthcare sector, built on a 7.65% return on equity and a P/E of 34.28x against an Industry P/E of 38.42x. Whether IOL Chemicals and Pharmaceuticals is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.
Is IOL Chemicals and Pharmaceuticals the best stock in its sector? The stock trades on the NSE at Rs 198 as of 29 September 2026, within its 52-week range of Rs 67.19 to Rs 219.04. IOL Chemicals and Pharmaceuticals Ltd manufactures ibuprofen and other active pharmaceutical ingredients and specialty chemicals.
IOL Chemicals and Pharmaceuticals sits in the Healthcare sector, and its 7.65% ROE and 34.28x P/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P/E benchmark.
Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers
Click Here – Get Free Investment Predictions
About IOL Chemicals and Pharmaceuticals
IOL Chemicals and Pharmaceuticals Ltd manufactures ibuprofen and other active pharmaceutical ingredients and specialty chemicals. The stock has nearly tripled from its 52-week low and rose over 1 percent during this session. At a market capitalisation of Rs 5,765 Cr, it is tracked as part of the Healthcare sector on Univest.
Is IOL Chemicals and Pharmaceuticals the Best Stock in Its Sector?
IOL Chemicals and Pharmaceuticals makes its case as the best stock in its sector primarily on valuation relative to its Industry P/E, combining a 7.65% ROE with a 34.28x P/E against the sector’s 38.42x Industry P/E. IOL Chemicals and Pharmaceuticals’ 34.28x P/E is close to the 38.42x Industry P/E, but a 7.65% ROE is modest for that multiple and the stock has nearly tripled from its 52-week low.
| Metric | IOL Chemicals and Pharmaceuticals |
|---|---|
| CMP (NSE) | Rs 198.48 |
| 52-Week High / Low | Rs 219.04 / Rs 67.19 |
| Market Cap | Rs 5,765 Cr |
| P/E (TTM) vs Industry P/E | 34.28x vs 38.42x |
| P/B | 3.21 |
| ROE | 7.65% |
| EPS (TTM) | Rs 5.73 |
| Dividend Yield | 0.51% |
| Debt to Equity | 0.08 |
Compare IOL Chemicals and Pharmaceuticals Against Other Healthcare Sector Stocks
How IOL Chemicals and Pharmaceuticals Compares Against Its Healthcare Sector Peers
The table below sets IOL Chemicals and Pharmaceuticals against 2 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 2 peer companies.
| Company | Market Cap (Rs Cr) | P/E | ROE | Debt to Equity |
|---|---|---|---|---|
| IOL Chemicals and Pharmaceuticals | 5,765 | 34.28 | 7.65% | 0.08 |
| Gujarat Themis Biosyn | 5,431 | 111.58 | 16.22% | 0.56 |
| Blue Jet Healthcare | 11,075 | 47.15 | 18.22% | 0.03 |
| Peer average (2 companies) | – | 79.36 | 17.22% | 0.30 |
Against this peer set, IOL Chemicals and Pharmaceuticals’s 7.65% ROE is below the 17.22% peer average, and its P/E of 34.28x runs below the peer average of 79.36x. IOL Chemicals and Pharmaceuticals’ 34.28x P/E is close to the 38.42x Industry P/E, but a 7.65% ROE is modest for that multiple and the stock has nearly tripled from its 52-week low.
What Makes IOL Chemicals and Pharmaceuticals Worth Watching in Healthcare
- Low leverage: A debt to equity ratio of 0.08 is very comfortable.
- Close to Industry P/E: A 34.28x P/E versus a 38.42x Industry P/E shows the stock trading near sector norms.
- Sharp rally: The share price has nearly tripled from its 52-week low, so much of the improvement is already priced in.
IOL Chemicals and Pharmaceuticals Valuation: Is It Justified?
IOL Chemicals and Pharmaceuticals’ 34.28x P/E is close to the 38.42x Industry P/E, but a 7.65% ROE is modest for that multiple and the stock has nearly tripled from its 52-week low. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.
Also read – Is Indegene the Best Stock in Its Sector? A Look at the Numbers
Download the Univest iOS App or Univest Android App to track IOL Chemicals and Pharmaceuticals and other Healthcare sector stocks.
How to Track IOL Chemicals and Pharmaceuticals Before You Invest
Before deciding whether IOL Chemicals and Pharmaceuticals deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.
- Open the Univest Screener and search for IOL Chemicals and Pharmaceuticals to view live price, valuation ratios, and peer comparisons within the Healthcare sector.
- Compare its P/E, P/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.
- Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
- Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.
Conclusion
IOL Chemicals and Pharmaceuticals earns a place in the best stock in its sector conversation on the strength of a 7.65% ROE and a P/E of 34.28x against a 38.42x Industry P/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Is IOL Chemicals and Pharmaceuticals the best stock in its sector?
Ans. IOL Chemicals and Pharmaceuticals has a 7.65% ROE and trades at 34.28x P/E against a 38.42x Industry P/E, and compares below the peer average ROE of 17.22% in this article’s named comparison, so the answer depends on what an investor is prioritising.
What is the current share price of IOL Chemicals and Pharmaceuticals?
Ans. IOL Chemicals and Pharmaceuticals was trading at Rs 198.48 on the NSE as of 29 September 2026, within its 52-week range of Rs 67.19 to Rs 219.04.
What sector does IOL Chemicals and Pharmaceuticals belong to?
Ans. IOL Chemicals and Pharmaceuticals is classified under the Healthcare sector on Univest.
How does IOL Chemicals and Pharmaceuticals compare to its sector peers on P/E?
Ans. IOL Chemicals and Pharmaceuticals’s P/E of 34.28x is below the 79.36x average of the 2 named peers compared in this article.
What is IOL Chemicals and Pharmaceuticals’s return on equity?
Ans. IOL Chemicals and Pharmaceuticals reported a return on equity of 7.65%, which is below the 17.22% average of its named peers in this comparison.
Should I invest in IOL Chemicals and Pharmaceuticals based on its sector position?
Ans. IOL Chemicals and Pharmaceuticals’s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.
